Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Menadione Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021 2 0
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 14
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5
Interferon beta-1a Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 2 1
Auranofin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/29/2020 2 0